Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 …
SJ Park, HT Kim, DH Lee, KP Kim, SW Kim, C Suh… - Lung cancer, 2012 - Elsevier
Non-small cell lung cancer (NSCLC) harboring an activating epidermal growth factor
receptor (EGFR) mutation shows good and rapid response to EGFR tyrosine kinase …
receptor (EGFR) mutation shows good and rapid response to EGFR tyrosine kinase …
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 …
SJ Park, HT Kim, DH Lee, KP Kim, SW Kim… - Lung Cancer …, 2012 - europepmc.org
Non-small cell lung cancer (NSCLC) harboring an activating epidermal growth factor
receptor (EGFR) mutation shows good and rapid response to EGFR tyrosine kinase …
receptor (EGFR) mutation shows good and rapid response to EGFR tyrosine kinase …
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 …
SJ Park, HT Kim, DH Lee, KP Kim, SW Kim… - Lung …, 2012 - lungcancerjournal.info
Non-small cell lung cancer (NSCLC) harboring an activating epidermal growth factor
receptor (EGFR) mutation shows good and rapid response to EGFR tyrosine kinase …
receptor (EGFR) mutation shows good and rapid response to EGFR tyrosine kinase …
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 …
SJ Park, HT Kim, DH Lee, KP Kim, SW Kim, C Suh… - Lung Cancer, 2012 - infona.pl
Non-small cell lung cancer (NSCLC) harboring an activating epidermal growth factor
receptor (EGFR) mutation shows good and rapid response to EGFR tyrosine kinase …
receptor (EGFR) mutation shows good and rapid response to EGFR tyrosine kinase …
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 …
SJ Park, HT Kim, DH Lee, KP Kim… - Lung cancer …, 2012 - pubmed.ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) harboring an activating epidermal growth factor
receptor (EGFR) mutation shows good and rapid response to EGFR tyrosine kinase …
receptor (EGFR) mutation shows good and rapid response to EGFR tyrosine kinase …
[引用][C] Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 …
SJ PARK, HT KIM, DH LEE, KP KIM, SW KIM… - Lung …, 2012 - pascal-francis.inist.fr
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in
non-small cell lung cancer patients harboring either exon 19 or 21 mutation CNRS Inist …
non-small cell lung cancer patients harboring either exon 19 or 21 mutation CNRS Inist …
[引用][C] Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 …
SJ Park, HT Kim, DH Lee, KP Kim, SW Kim, C Suh… - Lung Cancer, 2012 - cir.nii.ac.jp
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in
non-small cell lung cancer patients harboring either exon 19 or 21 mutation | CiNii Research …
non-small cell lung cancer patients harboring either exon 19 or 21 mutation | CiNii Research …